Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Phenoxybenzamine MeSH Descriptor Data 2025


MeSH Heading
Phenoxybenzamine
Tree Number(s)
D02.092.471.739
Unique ID
D010643
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D010643
Scope Note
An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Entry Term(s)
Dibenylene
Dibenyline
Dibenziran
Dibenzylin
Dibenzyline
Dibenzyran
Phenoxybenzamine Hydrochloride
Pharm Action
Adrenergic alpha-Antagonists
Antihypertensive Agents
Vasodilator Agents
Registry Numbers
0TTZ664R7Z
X1IEG24OHL
0
Related Numbers
59-96-1
63-92-3
X1IEG24OHL
CAS Type 1 Name
Benzenemethanamine, N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-
NLM Classification #
QV 132
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2016/07/01
Phenoxybenzamine Preferred
Phenoxybenzamine Hydrochloride Narrower
Dibenyline Narrower
Dibenzyline Narrower
Dibenziran Narrower
page delivered in 0.127s